… is set to go off-patent next year. “Filing will … once the patent expires. However, Mittal believes Biocon’s existing … impetus". Biosimilar growth Biocon's biosimilars business, … successful new product launches. Biocon Biologics has introduced four …

… innovator had inked several patent settlements with several drugmakers including … in the US market. Biocon’s Yesintik is stated to … its patient support program My Biocon Biologics, as prefilled syringes … Tambe, CEO and MD, Biocon Biologics. Published On Oct 23 …

Regeneron has settled its patent dispute with Celltrion, giving … The deal settles all patent litigation between the two companies … Mylan Pharmaceuticals—plus partner Biocon Biologics—have all been … prescription from a doctor. Biocon and Mylan became the first …

… , 2025, asserting 34 patents.  At issue were Biocon’s denosumab biosimilars BOSAYA … the Consent Judgment, Biocon agreed that all 34 asserted patents are “valid … , enforceable and infringed” by Biocon’s denosumab …

… . The firm will use its patented technology to design mRNA vaccines … AG Amgen Inc. Syngenta AG Biocon Limited Biogen Inc. F. Hoffmann …

… agreement to resolve the pending patent litigation at the United States … Tambe, CEO & Managing Director, Biocon Biologics, said, "This settlement … 00. Source : Equity Bulls Keywords Biocon INE376G01013 Biotechnology BioconBiologics Settlement License …

… company and subsidiary of Biocon Ltd., has announced a … patients, associated with BOSAYA. Biocon Biologics and Amgen executed the … to resolve the pending patent litigation at the United … CEO & Managing Director, Biocon Biologics, said, “This settlement …

… . The settlement agreement resolves ongoing patent litigation at the United States … District of New Jersey, allowing Biocon Biologics to officially launch Bosaya … remain confidential. This development strengthens Biocon Biologics’ footprint in the U …

… 100% tariff on branded and patented drugs starting Oct. 1.  The … and reliance on branded or patented formulations.  He noted that Syngene … Dr. Reddy’s Laboratories and Biocon, will need to accelerate U … is down 7.2%, and Biocon has fallen 6.3%. For …

… new set of tariffs targeting patented and branded drugs. The … Tariff on any branded or patented Pharmaceutical Product, unless a Company … steep declines—including Sun Pharma, Biocon, Divi’s Labs, and … ? The 100% tariffs on patented drugs were one of several …